Single-use market to reach $20.8bn by 2026
Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product.
The "Global Forecast 2026" comprises Media Bags and containers, Bioreactors, Mixers, Assemblies, Applications (Cell Culture, Mixing, Storage, Filtration, Purification), and names the most relevant developers, and CDMOs. Global sales are expected to reach US-$20.8bn by 2026 from US-$8.2bn 2021, at a CAGR of 20.5% during the forecast period.
Single-use bioprocessing is a flexible, cost-effective but not sustainable method to manufacture biologiscals such as recombinant proteins, monoclonal antibodies and conjugates, vaccines, or cell-based therapeutics.
Biocytogen Co Ltd
Draupnir Bio ApS